For nearly two decades, electronic cigarettes have been marketed under the guise of a "clean" or "safe" alternative to traditional combustible tobacco. This narrative has been remarkably effective, fueling a massive surge in use among adolescents and young adults who operate under the dangerous assumption of a zero-health risk. However, as the medical community moves past the marketing fog, the latest clinical evidence reveals a disturbing molecular footprint and a systemic health legacy that the industry rarely discusses.

Heart disease is often culturally coded as an "old man’s problem", a condition of the silver-haired and the sedentary. This stereotype is not just inaccurate; it is lethal. Every year, more than 15,000 women in the United States under the age of 55 die from heart disease, making it a leading cause of death for this demographic.

The tragedy lies in the disparity of outcomes. Research reveals that young women have twice the risk of dying during a hospitalization for an acute myocardial infarction (AMI) compared to men of the same age. For those who survive the initial event, the road ahead remains treacherous: their subsequent mortality risk is approximately 50% higher than their male counterparts.

We think of smartwatches as tools for convenience, tracking our steps, displaying our messages, and monitoring our workouts. But this familiar technology is quietly evolving into something far more profound. The target is one of the most critical challenges in emergency medicine: unwitnessed out-of-hospital cardiac arrest (OHCA).

Few scenarios are more frightening for a patient or family member than a medical emergency. In those moments of crisis, we place our complete trust in the medical team, assuming every responder is flawlessly prepared to perform life-saving procedures. We expect perfection because the stakes are unimaginably high. But how do new staff get the training they need to achieve that level of skill, especially for events that are, thankfully, rare?